GoldState Music and Bridgepoint Announce Strategic Partnership Targeting Growth Investments February 26, 2026 Capital will support GoldState Music’s Growth Strategy which will invest in scalable, profitable music-oriented businesses across the music value chain Bridgepoint commits a significant investment as lead investor in GoldState’s Growth Strategy
Fourth Launches Fourth iQ 3.0, Giving Senior Restaurant Leaders Control and Visibility Over Store Performance February 26, 2026 Fourth, the leading provider of workforce and inventory management solutions for the hospitality industry, today announced the launch of Fourth iQ 3.0, introducing a significant new layer of above-store AI capabilities built for executives and operations teams responsible for multi-location performance. The release complements Fourth iQ’s in-store AI capabilities, including Forecasting and Next Best Actions, [...]
Lone Star Agrees to Acquire Central London Office Building February 26, 2026 Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Real Estate Fund VII, L.P. has reached an agreement to acquire 90 Whitfield Street in London, UK from Derwent London. The property, located in central London’s West End sub-market of Fitzrovia, is comprised of 107,000 total square-feet with 99,000 square-feet dedicated to [...]
Fluidra Delivers Strong 2025 Results, Advancing Its Strategic Priorities February 26, 2026 Sales up 7% on constant currency to €2,184 million with volume growth across all regions and positive price contribution Net income of €176 million, up 28% Successful completion of the €100 million savings set under its Simplification Plan Proposes 2025 dividend distribution of 65 euro cents per share, up 8%
CoStar Data Show Sharp London Office Yield Compression in 2025 February 26, 2026 Rising investor demand drove London office yields to their lowest level since 2023, according to data from CoStar, a global leading provider of online real estate marketplaces, information and analytics in the property markets. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260226000995/en/ Based on a three-period trailing average, the transaction-based office yield [...]
Allianz Achieves Record Operating Profit of 17.4 Billion Euros – Excellent Start to New Strategic Cycle February 26, 2026 12M 2025 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260225107874/en/ Excellent momentum and record operating profit Total business volume rises 8.11 percent and reaches 186.9 billion euros with contributions from all segments Operating profit increases 8.4 percent to 17.4 billion euros, our highest operating profit ever Shareholders’ core net income advances 10.9 [...]
Indra Group Exceeds All Its Guidances in 2025 and Sets Even More Ambitious Guidances for 2026 Than Those Set Out in Its ‘Leading the Future’ Strategic Plan February 25, 2026 Results in fiscal year 2025 Revenues increased by 13%, totaling €5.457 billion in 2025 Indra Group sets financial guidances at least 17% higher than those foreseen in its Strategic Plan for 2026 Indra Group announces the payment of a €0.30 dividend per share (more than 20% above the dividend in 2024) charged to the earnings posted in 2025 The results and the increase in the order intake confirm Indra Group’s industrial strength and its capacity to tackle and execute the major defence modernization programs
Amadeus Acquires SkyLink to Accelerate the Deployment of AI in Travel February 25, 2026 As the industry moves from AI proof of concepts to adoption, Amadeus takes the next step in delivering meaningful AI use cases at scale with the acquisition of SkyLink Amadeus to enable smarter, more automated and faster travel bookings by adding SkyLink’s AI-driven conversational technology to its product portfolio to assist travelers and employees on the road
ViiV Healthcare presents pipeline data for two investigational HIV treatment therapies with potential for twice-yearly dosing February 25, 2026 VH184, the first, third‑generation integrase inhibitor in development shows potential for up to twice-yearly dosing intervals Additional in-vitro data on VH184 demonstrate improved potency and an enhanced resistance profile versus bictegravir VH499 demonstrates good tolerability, supporting twice-yearly dosing intervals
ViiV Healthcare reports positive 12-month data showing investigational bNAb lotivibart (N6LS) maintains high levels of viral suppression in long-acting HIV treatment regimen February 25, 2026 94% of adults on stable therapy maintained viral suppression with intravenous lotivibart dosed every four months in combination with long-acting cabotegravir These phase IIb results reinforce lotivibart’s ultra long-acting potential, with the trial progressing to evaluate a twice-yearly intravenous dosing interval